New York State Contract Reporter #27-313-902

SUNY Downstate Health Sciences University Solicits Molecular Testing Platform with 5-Year Service Plan

SUNY Downstate Health Sciences University Clinical Laboratories is seeking a Molecular Testing Platform for Pathogen Detection and Identification, along with a five-year comprehensive service agreement. - Government Buyer: - State University of New York (SUNY) – SUNY Downstate Health Sciences University Clinical Laboratories - Products/Services Requested: - Molecular Testing Platform (1 unit) - Must run FDA-approved assays for: - Herpes simplex virus (HSV) 1 & 2 (CSF, cutaneous, mucocutaneous lesion swabs) - Varicella zoster virus (VZV) (cutaneous, mucocutaneous lesion swabs) - Cytomegalovirus (CMV) (saliva, urine) - Candida auris (axilla/groin swabs) - Technical requirements: - Assay runtime: 2 hours or less - Minimum capacity: 8 samples simultaneously - Benchtop size: max 12" x 12" x 12" - Weight: max 30 lbs - Cerner LIS connectivity - 110V electrical compatibility - Five-year service agreement - Toll-free customer service (Mon-Fri, 7:30AM-5:00PM PST) - 48-hour replacement service (shipping/handling included) - Annual preventive maintenance and recertification - All repair service and parts - Preventive maintenance at manufacturer-recommended frequency - Required software upgrades - Loaner unit during extended downtime - Unique/Notable Requirements: - Vendors must demonstrate experience in manufacturing, supplying, and supporting such instruments - Must provide three references from hospitals or academic medical centers - Emphasis on best value/qualified vendor selection - Compliance with New York State affirmative action and MWBE participation requirements - No specific OEMs or vendors are named in the solicitation

Description

SUNY Downstate Health Sciences University Clinical Laboratory is seeking to purchase a Molecular Testing Platform for Pathogen Detection and Identification for use in the Clinical Microbiology Laboratory. The procurement includes the instrument and an associated five-year service plan. The platform must be capable of running FDA-approved assays for specific pathogens from clinical specimens, have a minimum capacity of 8 samples, and meet size and connectivity requirements. The contract term is five years, and proposals must be submitted via email by August 26, 2026.

View original listing